Cardinal Health, Inc. $CAH Stock Holdings Decreased by Allen Mooney & Barnes Investment Advisors LLC

Allen Mooney & Barnes Investment Advisors LLC cut its holdings in Cardinal Health, Inc. (NYSE:CAH) by 2.1% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 6,610 shares of the company’s stock after selling 144 shares during the period. Allen Mooney & Barnes Investment Advisors LLC’s holdings in Cardinal Health were worth $1,110,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Greykasell Wealth Strategies Inc. acquired a new position in Cardinal Health during the 1st quarter valued at about $26,000. Jones Financial Companies Lllp lifted its stake in Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the last quarter. Tompkins Financial Corp lifted its stake in Cardinal Health by 106.7% during the first quarter. Tompkins Financial Corp now owns 248 shares of the company’s stock valued at $34,000 after purchasing an additional 128 shares during the last quarter. GW&K Investment Management LLC lifted its stake in Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after purchasing an additional 144 shares during the last quarter. Finally, NBC Securities Inc. acquired a new stake in shares of Cardinal Health during the first quarter valued at approximately $48,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Cardinal Health

In other Cardinal Health news, CEO Jason M. Hollar sold 35,901 shares of the firm’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total value of $5,386,586.04. Following the completion of the sale, the chief executive officer owned 200,000 shares in the company, valued at approximately $30,008,000. This trade represents a 15.22% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the sale, the insider owned 15,431 shares of the company’s stock, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 271,676 shares of company stock worth $40,489,525. Corporate insiders own 0.09% of the company’s stock.

Cardinal Health Stock Performance

NYSE:CAH opened at $152.34 on Monday. The company has a 50-day moving average of $154.50 and a 200-day moving average of $147.93. The company has a market capitalization of $36.38 billion, a price-to-earnings ratio of 23.62, a PEG ratio of 1.29 and a beta of 0.73. Cardinal Health, Inc. has a 52 week low of $106.54 and a 52 week high of $168.44.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same period last year, the firm earned $1.84 EPS. The firm’s revenue for the quarter was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 31.63%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. UBS Group restated a “buy” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Wall Street Zen lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Morgan Stanley reaffirmed an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Citigroup reaffirmed a “neutral” rating and set a $170.00 price objective (up from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Finally, Evercore ISI reduced their price target on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a report on Wednesday, August 13th. Eleven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $165.93.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.